PRM.MC
Price:
$13.85
Market Cap:
$235.70M
Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
Industry
Medical - Instruments & Supplies
IPO Date
2005-04-01
Stock Exchange
BME
Ticker
PRM.MC
According to Prim, S.A.’s latest financial reports and current stock price. The company's current ROE is 11.12%. This represents a change of 302.41% compared to the average of 2.76% of the last 4 quarters.
The mean historical ROE of Prim, S.A. over the last ten years is 10.69%. The current 11.12% ROE has changed 4.11% with respect to the historical average. Over the past ten years (40 quarters), PRM.MC's ROE was at its highest in in the December 2021 quarter at 5.68%. The ROE was at its lowest in in the March 2018 quarter at 0%.
Average
10.69%
Median
10.85%
Minimum
6.19%
Maximum
14.34%
Discovering the peaks and valleys of Prim, S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 131.71%
Maximum Annual ROE = 14.34%
Minimum Annual Increase = -51.13%
Minimum Annual ROE = 6.19%
| Year | ROE | Change |
|---|---|---|
| 2024 | 8.47% | -15.91% |
| 2023 | 10.07% | 43.69% |
| 2022 | 7.01% | -51.13% |
| 2021 | 14.34% | 131.71% |
| 2020 | 6.19% | -38.72% |
| 2019 | 10.10% | -22.13% |
| 2018 | 12.97% | -1.00% |
| 2017 | 13.10% | 0.89% |
| 2016 | 12.99% | 11.93% |
| 2015 | 11.60% | 7.93% |
The current ROE of Prim, S.A. (PRM.MC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.52%
5-year avg
9.22%
10-year avg
10.69%
Prim, S.A.’s ROE is less than Laboratorio Reig Jofre, S.A. (4.12%), greater than Atrys Health, S.A. (-9.94%), greater than Oryzon Genomics S.A. (-4.20%), greater than Pangaea Oncology, S.A. (-6.08%), greater than Biotechnologies Assets S.A. (-41.71%), less than Clínica Baviera, S.A. (40.99%),
| Company | ROE | Market cap |
|---|---|---|
| 4.12% | $227.89M | |
| -9.94% | $205.75M | |
| -4.20% | $252.33M | |
| -6.08% | $58.04M | |
| -41.71% | $19.89M | |
| 40.99% | $766.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prim, S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prim, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Prim, S.A.'s ROE?
How is the ROE calculated for Prim, S.A. (PRM.MC)?
What is the highest ROE for Prim, S.A. (PRM.MC)?
What is the 3-year average ROE for Prim, S.A. (PRM.MC)?
What is the 5-year average ROE for Prim, S.A. (PRM.MC)?
How does the current ROE for Prim, S.A. (PRM.MC) compare to its historical average?